Bausch Cash And Short Term Investments vs Other Stockholder Equity Analysis
BHC Stock | USD 6.95 0.08 1.14% |
Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Cash And Short Term Investments and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Cash And Short Term Investments vs Other Stockholder Equity
Cash And Short Term Investments vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Cash And Short Term Investments account and Other Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Bausch Health's Cash And Short Term Investments and Other Stockholder Equity is 0.42. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Cash And Short Term Investments and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Bausch Health Companies are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Cash And Short Term Investments i.e., Bausch Health's Cash And Short Term Investments and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Bausch Health Companies balance sheet. This account contains Bausch Health investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Bausch Health Companies fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Other Stockholder Equity
Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At present, Bausch Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.31, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.0B | 5.8B | 6.2B | 6.5B | Total Revenue | 8.4B | 8.1B | 8.8B | 9.2B |
Bausch Health fundamental ratios Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Short Long Term Debt Total | 25.9B | 23.9B | 22.7B | 20.8B | 22.4B | 23.5B | |
Other Current Liab | 2.1B | 4.6B | 4.8B | 3.0B | 1.0B | 1.2B | |
Total Current Liabilities | 6.2B | 4.9B | 5.2B | 3.9B | 4.3B | 4.5B | |
Total Stockholder Equity | 1.1B | 535M | (106M) | (692M) | (1.0B) | (970.9M) | |
Property Plant And Equipment Net | 1.5B | 1.6B | 1.6B | 1.6B | 1.7B | 1.8B | |
Net Debt | 22.7B | 23.3B | 22.1B | 20.2B | 21.4B | 22.5B | |
Retained Earnings | (7.5B) | (8.0B) | (9.0B) | (9.2B) | (9.8B) | (9.3B) | |
Accounts Payable | 503M | 337M | 407M | 521M | 719M | 755.0M | |
Cash | 3.2B | 605M | 582M | 564M | 947M | 502.7M | |
Non Current Assets Total | 26.9B | 25.9B | 23.6B | 21.4B | 21.8B | 12.7B | |
Non Currrent Assets Other | 411M | 664M | 340M | 326M | 307M | 236.2M | |
Cash And Short Term Investments | 3.2B | 605M | 582M | 564M | 947M | 506.0M | |
Net Receivables | 1.8B | 1.6B | 1.8B | 1.8B | 2.0B | 2.1B | |
Common Stock Shares Outstanding | 352.1M | 355M | 358.9M | 362M | 364.9M | 246.3M | |
Liabilities And Stockholders Equity | 33.9B | 31.2B | 29.2B | 25.7B | 27.4B | 14.9B | |
Non Current Liabilities Total | 26.5B | 25.7B | 24.0B | 21.5B | 23.1B | 24.3B | |
Other Current Assets | 779M | 855M | 720M | 776M | 1.1B | 1.1B | |
Other Stockholder Equity | 429M | 454M | 462M | 159M | 214M | 203.3M | |
Total Liab | 32.7B | 30.6B | 29.2B | 25.4B | 27.4B | 28.8B | |
Property Plant And Equipment Gross | 1.5B | 1.6B | 3.4B | 3.5B | 3.8B | 4.0B | |
Total Current Assets | 7.0B | 5.3B | 5.6B | 4.2B | 5.6B | 5.9B | |
Accumulated Other Comprehensive Income | (2.1B) | (2.1B) | (1.9B) | (2.1B) | (1.9B) | (1.8B) | |
Short Term Debt | 1.2B | 52M | 49.9M | 432M | 450M | 472.5M | |
Intangible Assets | 10.2B | 8.4B | 6.9B | 5.8B | 6.5B | 5.8B | |
Inventory | 1.1B | 1.1B | 993M | 1.1B | 1.5B | 1.6B | |
Common Stock Total Equity | 10.2B | 10.2B | 10.3B | 10.4B | 11.9B | 7.0B | |
Common Stock | 10.2B | 10.2B | 10.3B | 10.4B | 10.4B | 6.1B | |
Other Liab | 1.6B | 1.5B | 1.2B | 967M | 1.1B | 1.3B | |
Current Deferred Revenue | 2.4B | (52M) | (49.9M) | 2.1B | 2.4B | 2.5B | |
Other Assets | 1.8B | 2.8B | 2.3B | 2.3B | 2.6B | 2.7B | |
Long Term Debt | 24.7B | 23.9B | 22.7B | 20.3B | 21.9B | 14.0B | |
Good Will | 13.1B | 13.0B | 12.5B | 11.5B | 11.2B | 7.2B | |
Property Plant Equipment | 1.5B | 1.6B | 1.6B | 1.8B | 2.1B | 2.2B | |
Net Tangible Assets | (22.3B) | (21.0B) | (19.5B) | (18.0B) | (16.2B) | (17.0B) | |
Noncontrolling Interest In Consolidated Entity | 73M | 70M | 72M | 952M | 1.1B | 1.1B | |
Retained Earnings Total Equity | (7.5B) | (8.0B) | (9.0B) | (9.2B) | (8.3B) | (7.9B) | |
Long Term Debt Total | 24.7B | 23.9B | 22.7B | 20.3B | 23.4B | 21.5B |
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
0.71 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.115 | Earnings Share (1.24) | Revenue Per Share 24.512 | Quarterly Revenue Growth 0.108 | Return On Assets 0.0404 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.